Valentina Kutyifa
Overview
Explore the profile of Valentina Kutyifa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
269
Citations
2202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goldenberg I, Ezekowitz J, Albert C, Alexis J, Anderson L, Behr E, et al.
Heart Rhythm
. 2025 Feb;
PMID: 39918486
The main function of the implantable cardioverter-defibrillator (ICD) is to protect against sudden cardiac death (SCD) due to ventricular tachyarrhythmia (VTA). Current guidelines provide a recommendation to implant a prophylactic...
2.
Goldenberg I, Ezekowitz J, Albert C, Alexis J, Anderson L, Behr E, et al.
J Card Fail
. 2025 Feb;
PMID: 39915204
The main function of the implantable cardioverter-defibrillator (ICD) is to protect against sudden cardiac death (SCD) due to ventricular tachyarrhythmia (VTA). Current guidelines provide a recommendation to implant a prophylactic...
3.
Shoamanesh A, Field T, Coutts S, Sharma M, Gladstone D, Hart R, et al.
Lancet Neurol
. 2025 Jan;
24(2):140-151.
PMID: 39862882
Background: People with subclinical atrial fibrillation are at increased risk of stroke, albeit to a lesser extent than those with clinical atrial fibrillation, leading to an ongoing debate regarding the...
4.
Kutyifa V, Christof M, Mullane S, Harrell C, Singh J, Chinitz L, et al.
Heart Rhythm O2
. 2024 Dec;
5(11):805-812.
PMID: 39651437
Background: There have been limited data examining the temporal relationship between device-derived daily activity and ventricular arrhythmias (VAs). Objective: We aimed to assess whether activity predicted VAs or VAs predicted...
5.
Merkel E, Hatala R, Szigeti M, Schwertner W, Lakatos B, Behon A, et al.
JACC Heart Fail
. 2024 Nov;
13(2):265-273.
PMID: 39614838
Background: In the BUDAPEST (Biventricular Upgrade on left ventricular reverse remodeling and clinical outcomes in patients with left ventricular Dysfunction and intermittent or permanent APical/SepTal right ventricular pacing)-CRT Upgrade randomized...
6.
Wang M, Goldenberg I, Younis A, Goldenberg I, Christof M, Huang D, et al.
Heart Rhythm
. 2024 Nov;
PMID: 39581430
Background: There are limited data on clinical and arrhythmic outcomes after a first ventricular tachyarrhythmia (VTA) in heart failure (HF) patients who receive a primary prevention implantable cardioverter-defibrillator (ICD). Objective:...
7.
Goldenberg I, Younis A, Huang D, Rosero S, Kutyifa V, McNitt S, et al.
J Cardiovasc Electrophysiol
. 2024 Nov;
36(1):188-197.
PMID: 39533482
Introduction: The implantable cardioverter defibrillator reduces mortality among patients with heart failure (HF) due to ischemic heart disease. Clinical trial data have called into question the benefit of an ICD...
8.
Sudesh S, Abraham W, Cleland J, Curtis A, Friedman D, Gold M, et al.
JACC Heart Fail
. 2024 Oct;
12(11):1915-1924.
PMID: 39387768
Background: Data on whether cardiac resynchronization therapy (CRT) results in better clinical and echocardiographic outcomes in patients with nonischemic cardiomyopathy (NICM) vs ischemic cardiomyopathy (ICM) are conflicting. Objectives: The authors...
9.
Peek N, Hindricks G, Akbarov A, Tijssen J, Jenkins D, Kapacee Z, et al.
Eur Heart J
. 2024 Oct;
45(43):4616-4626.
PMID: 39378245
Background And Aims: Risk stratification of sudden cardiac death after myocardial infarction and prevention by defibrillator rely on left ventricular ejection fraction (LVEF). Improved risk stratification across the whole LVEF...
10.
Schnabel R, Benezet-Mazuecos J, Becher N, McIntyre W, Fierenz A, Lee S, et al.
Eur Heart J
. 2024 Sep;
45(46):4902-4916.
PMID: 39222018
Background And Aims: The optimal antithrombotic therapy in patients with device-detected atrial fibrillation (DDAF) is unknown. Concomitant vascular disease can modify the benefits and risks of anticoagulation. Methods: These pre-specified...